ARUSHA: DID you know Arusha has Africa’s rooftop (Mount Meru), the gateway to Mount Kilimanjaro, worldfamous national parks, world-class coffee, Africa’s largest Tanzanite reserves, and a conference ...
Pledge to invest billions in UK paused, with Washington citing lack of progress on trade barriers across pond The US has paused its promised multi-billion-pound investment into British tech over trade ...
As OpenAI marks its tenth birthday in December 2025, it can celebrate becoming one of the world’s leading companies, worth perhaps as much as US$1 trillion (£750 billion). But it started as a ...
The U.S. Citizenship and Immigration Services (USCIS) announced Tuesday it is placing a hold on all pending asylum applications and will pause all benefit requests by foreign nationals from 19 ...
Forbes contributors publish independent expert analyses and insights. Specialist in global markets, economics and alternative investments. Reading through dozens of 100-page investment outlooks to ...
Cory Lee was diagnosed with spinal muscular atrophy at age 2 Jordan Greene is Society and Culture writer-reporter at PEOPLE. She has been working at PEOPLE since 2023. Her work has previously appeared ...
Investment banks manage IPOs, helping with valuation and handling initial trading. In mergers, they offer crucial buy-side and sell-side advisory roles. Since 1999, banks can operate both investment ...
Rowan Street Capital, an investment management company, has recently released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund remained unchanged in the ...
SLR Investment Corp. offers an attractive 11.4% dividend yield, trades below book value, and maintains a strong cash position. SLRC stands out among BDC peers for its conservative leverage and ...
Good risk-adjusted yield has been hard to find lately. Some money pros are looking beyond traditional fixed-income categories. Where have all the good fixed-income opportunities gone? In recent months ...
Sept 16 (Reuters) - Microsoft (MSFT.O), opens new tab is planning to invest more than $30 billion in its UK operations and artificial intelligence infrastructure over the next four years, the software ...
The UK is losing ground in global pharmaceutical investment as major companies pause r&d projects. Rising costs, policy barriers, and shrinking incentives are driving Big Pharma away The UK’s ...